Home   Chapter Home   Jobs   Conferences   Fellowships   Books




Features to report - Cystectomy (total/partial), cystoprostatectomy, pelvic exenteration

Reviewer: Monika Roychowdhury, M.D., University of Minnesota Medical Center (see Reviewers page)
Revised: 3 July 2011, last major update May 2011
Copyright: (c) 2003-2011, PathologyOutlines.com, Inc.


Editorís note
● Mandatory / optional are for accreditation purposes by the American College of Surgeons Committee on Cancer

● Recommended to include clinically relevant historical information (Virchows Arch 2004;445:103)

● Specimen type / procedure
● Tumor size
● Tumor histologic type
● Tumor histologic grade
● Adequacy of specimen to determine muscularis propria invasion (muscularis propria found / not found / indeterminate)
● Lymphovascular invasion (present / absent / indeterminate)
● Pathologic stage (includes depth of invasion) (pTNM)
● Regional lymph nodes: either no nodes submitted or found, number examined / cannot be determined (explain), number involved (any size) / cannot be determined (explain); optional - extranodal extension of tumor
● Surgical margins: specify margins involved by invasive carcinoma or in situ carcinoma; if uninvolved by invasive carcinoma, specify distance from invasive carcinoma to margin
● Presence of tumor at margins of urethra, ureter, paravesicular soft tissue or pelvic soft tissue
● Involvement of adjacent structures: perivesical fat, ureter (specify laterality), urethra, vagina, uterus and adnexae, pelvic sidewall (specify laterality), prostate, seminal vesicle (specify laterality), rectum, other
● Additional epithelial lesions: papilloma, inverted papilloma, papillary neoplasm of low malignant potential

Optional but recommended:
● Site of tumor
● Tumor configuration (papillary, solid/nodule, flat, ulcerated, indeterminate)
● Additional findings: multifocality, carcinoma in situ, dysplasia, hyperplasia, inflammation, therapy related changes, keratinizing squamous metaplasia, intestinal metaplasia, inflammation/regenerative changes, cystitis cystica glandularis, urothelial carcinoma involving urethra/prostatic ducts and acini (use protocol for carcinoma of urethra)


Additional references

Mod Pathol 2009;22 Suppl 2:S70, Arch Pathol Lab Med 2003;127:1263

End of Bladder > Miscellaneous > Features to report - Cystectomy (total/partial), cystoprostatectomy, pelvic exenteration

This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.

All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at [email protected] with any questions (click here for other contact information).